subsets further displayed sustained markers of proliferation and CD4 T cell help, which were only transiently expressed in the CLN. A contribution of local CD4 T cell help to sustain B cell activation was supported by occasional B cells adjacent to T cells. The results suggest that accumulation of differentiated B cell subsets within the CNS is largely dictated by peripheral activation, but that local events contribute to their sustained activation independent of ectopic follicle formation.
a b s t r a c t
Central nervous system (CNS) inflammation associated with viral infection and autoimmune disease results in the accumulation of B cells in various differentiation stages. However, the contribution between peripheral and CNS activation remains unclear. During gliatropic coronavirus induced encephalomyelitis, accumulation of protective antibody secreting cells is preceded by infiltration of B cells with a naïve and early differentiation phenotype (Phares et al., 2014 subsets further displayed sustained markers of proliferation and CD4 T cell help, which were only transiently expressed in the CLN. A contribution of local CD4 T cell help to sustain B cell activation was supported by occasional B cells adjacent to T cells. The results suggest that accumulation of differentiated B cell subsets within the CNS is largely dictated by peripheral activation, but that local events contribute to their sustained activation independent of ectopic follicle formation. Ó 2016 Elsevier Inc. All rights reserved.
Introduction
Central nervous system (CNS) inflammation as a result of viral infection, tissue injury, or autoimmunity recruits B cell subsets in various differentiation stages ranging from naïve, unswitched and isotype class switched memory B cells (B mem ), and antibody secreting cells (ASC) (Ankeny et al., 2009; Cepok et al., 2005; Corcione et al., 2004; Cruz et al., 1987; Dang et al., 2015; Metcalf et al., 2013; Niino et al., 2009; Phares et al., 2014) . ASC and their antibody (Ab) specificity have been a major focus in multiple sclerosis (MS) research due to their potential reactivity to autoantigens. Although cerebrospinal fluid (CSF) immunoglobulin (Ig), a diagnostic hallmark, is suggested to be pathogenic, Ig specificity is diverse, rarely targeting myelin antigens (Avasarala et al., 2001; Cruz et al., 1987; Warren and Catz, 1994) . Interest in other functions of B cells emerged when clinical trials revealed that the anti-CD20 Ab, Rituximab, which depletes all B cells except ASC, improved clinical symptoms and reduced gadolinium-enhancing lesions in MS patients independent of changes in CSF Ig (Hauser et al., 2008) . By contrast, depletion of ASC and mature B cells using TACI Ig (Atacicept) in MS patients increased relapses ultimately resulting in the early termination of clinical trials (Kappos et al., 2014) . While the anti-CD20 studies implied a detrimental role for B cells during CNS inflammation apparently independent of Ig secretion, TACI Ig treatment suggested B cells may assume both pathogenic and protective roles during neuroinflammation.
Despite the commonality of distinct B cell subsets in injury, autoimmunity, and viral infection of the CNS, little is known about their activation state, maintenance, or function, especially in relation to peripheral immune activation. In addition to Ig secretion, B cells are important modulators of immune responses during CNS insults. Their functions include antigen presentation, thereby promoting CD4 T cell activities, production of pro-and antiinflammatory cytokines, and formation of follicle structures, which enhance and maintain local immune responses independent of the periphery (Claes et al., 2015; Michel et al., 2015; Owens et al., http://dx.doi.org/10.1016/j.bbi.2016.09.022 0889-1591/Ó 2016 Elsevier Inc. All rights reserved.
